Literature DB >> 7673487

Transplanted human neurons derived from a teratocarcinoma cell line (NTera-2) mature, integrate, and survive for over 1 year in the nude mouse brain.

S R Kleppner1, K A Robinson, J Q Trojanowski, V M Lee.   

Abstract

Retinoic acid (RA) induces a human teratocarcinoma cell line (NTera-2 or NT2) to give rise exclusively to post-mitotic neuron-like (NT2N) cells, but NT2N cells never acquire a fully mature neuronal phenotype in vitro. To determine whether NT2N cells can mature into adult neuron-like cells in vivo, purified NT2N cells were grafted into different regions of the central nervous system (CNS) of adult and neonatal athymic mice, and the grafts were examined immunohistochemically by light, confocal, and electron microscopy using antibodies to a panel of developmentally regulated neuronal polypeptides. NT2N grafts were distinguished from endogenous mouse neurons with antibodies that recognize human or murine specific epitopes in selected neuronal polypeptides. Viable NT2N cells were identified in > 89% of graft recipients (N = 90), and some grafts survived 14 months. Within 3 weeks of implantation, grafted NT2N cells re-extended their processes, and the location of the grafts (e.g., septum versus neocortex) appeared to determine the extent to which processes were elaborated. Within the early post-transplantation period, grafted NT2N cells expressed the same neuronal polypeptides as their in vitro counterparts. However, between 6 weeks and 4-6 months post-implantation, the grafted NT2N cells progressively acquired the molecular phenotype of fully mature in vivo neurons as evidenced by dramatically increased expression of the most highly phosphorylated isoforms of the heavy neurofilament subunit, and the de novo expression of adult CNS tau. Notably, the time course for the extension of processes and the expression of neuronal polypeptides by NT2N grafts was similar in neonatal and adult mice. Although grafted NT2N cells formed synapse-like structures and elaborated dendrites and axons, these axons remained unmyelinated. Finally, none of the transplanted NT2N cells reverted to a neoplastic state. These studies demonstrate that pure populations of grafted human NT2N cells acquire a fully mature neuronal phenotype in vivo, and that these cells integrate and survive for > 1 year post-implantation in the mouse CNS. These human neuron-like cells are an attractive model system for studies of neuronal development, polarity and transplantation.

Entities:  

Mesh:

Year:  1995        PMID: 7673487     DOI: 10.1002/cne.903570410

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  21 in total

Review 1.  From teratocarcinomas to embryonic stem cells.

Authors:  Peter W Andrews
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2002-04-29       Impact factor: 6.237

Review 2.  Cell therapy for stroke.

Authors:  Sean I Savitz; Jonathan H Dinsmore; Lawrence R Wechsler; Daniel M Rosenbaum; Louis R Caplan
Journal:  NeuroRx       Date:  2004-10

3.  The innate immune facet of brain: human neurons express TLR-3 and sense viral dsRNA.

Authors:  Monique Lafon; Françoise Megret; Mireille Lafage; Christophe Prehaud
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

4.  Developing safe therapies from human pluripotent stem cells.

Authors:  Melissa K Carpenter; Joyce Frey-Vasconcells; Mahendra S Rao
Journal:  Nat Biotechnol       Date:  2009-07       Impact factor: 54.908

Review 5.  Physiological relevance and functional potential of central nervous system-derived cell lines.

Authors:  S R Whittemore; E Y Snyder
Journal:  Mol Neurobiol       Date:  1996-02       Impact factor: 5.590

Review 6.  Innovative strategies in the management of acute stroke.

Authors:  Lawrence R Wechsler
Journal:  Curr Cardiol Rep       Date:  2002-03       Impact factor: 2.931

7.  Virus infection switches TLR-3-positive human neurons to become strong producers of beta interferon.

Authors:  Christophe Préhaud; Françoise Mégret; Mireille Lafage; Monique Lafon
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

8.  Neurotrophin and neurotrophin receptor proteins in medulloblastomas and other primitive neuroectodermal tumors of the pediatric central nervous system.

Authors:  K Washiyama; Y Muragaki; L B Rorke; V M Lee; S C Feinstein; M J Radeke; D Blumberg; D R Kaplan; J Q Trojanowski
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

9.  MCP-1-induced migration of NT2 neuroprogenitor cells involving APP signaling.

Authors:  Emmanuel George Vrotsos; Kiminobu Sugaya
Journal:  Cell Mol Neurobiol       Date:  2008-12-02       Impact factor: 5.046

Review 10.  Stem cells for ischemic brain injury: a critical review.

Authors:  Terry C Burns; Catherine M Verfaillie; Walter C Low
Journal:  J Comp Neurol       Date:  2009-07-01       Impact factor: 3.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.